342 related articles for article (PubMed ID: 32097657)
1. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
[TBL] [Abstract][Full Text] [Related]
2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
3. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
[TBL] [Abstract][Full Text] [Related]
4. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
[TBL] [Abstract][Full Text] [Related]
5. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.
Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222
[TBL] [Abstract][Full Text] [Related]
6. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
7. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
8. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.
Conti P; Stellin L; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560266
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
10. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
12. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
[TBL] [Abstract][Full Text] [Related]
13. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation.
Wu Z; Zhang J; Nakanishi H
J Neuroimmunol; 2005 Oct; 167(1-2):90-8. PubMed ID: 16095726
[TBL] [Abstract][Full Text] [Related]
15. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
[TBL] [Abstract][Full Text] [Related]
17. Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.
Zhang X; Dong H; Li N; Zhang S; Sun J; Zhang S; Qian Y
J Neuroinflammation; 2016 May; 13(1):127. PubMed ID: 27245661
[TBL] [Abstract][Full Text] [Related]
18. Impact of mold on mast cell-cytokine immune response.
Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P
J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
[TBL] [Abstract][Full Text] [Related]
20. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
